Therapeutic Implications of Tumor Free Margins in Head and Neck Squamous Cell Carcinoma
Overview
Authors
Affiliations
Objectives: The resection status is one of the most important prognostic factors for patients with head and neck squamous cell carcinoma (HNSCC) concerning overall survival (OS) and recurrence free interval (RFI). To assess whether therapy concepts changed depending on different resection margins and extracapsular extension, OS and RFI data were set into clinical context.
Methods: All HNSCC patients who underwent head and neck surgery with/without adjuvant therapy (n=534) were selected over a ten-year period (2001-2011). Clinical parameters and survival data were collected retrospectively and histopathological analysis of tumor free margins and extracapsular extension were done.
Results: Patients with microscopic resection showed mean OS/RFI of 95/96 months. OS/RFI decreased in microscopic macroscopic (56/58 and 35/39 months) as well as in unclear resection margins (63/60 months). Patients with extracapsular extension, microscopic - resection as well as patients with resection after follow up resection demonstrated therapy escalation by adjuvant (chemo-) radiation.
Conclusions: Insufficient surgical margins and extracapsular extension are main risks for a reduced overall and recurrence free survival. Although there is no measure to prevent positive extracapsular extension, clear margins at first pass protect patients from adjuvant therapy escalation.
Abu Taha S, Hejleh T, Wahbeh L, Alzibdeh A, Berawi M, Qambar M Front Oncol. 2024; 14:1443367.
PMID: 39464708 PMC: 11502470. DOI: 10.3389/fonc.2024.1443367.
Rethinking Surgical Margins: A New Approach to Predict Outcomes in Oral Squamous Cell Carcinoma.
Dudkiewicz D, Yosefof E, Shpitzer T, Mizrachi A, Yehuda M, Shoffel-Havakuk H Laryngoscope. 2024; 135(1):161-167.
PMID: 39230351 PMC: 11635150. DOI: 10.1002/lary.31744.
Surgical margins in head and neck squamous cell carcinoma: A narrative review.
Chen Y, Zhong N, Cao L, Liu B, Bu L Int J Surg. 2024; 110(6):3680-3700.
PMID: 38935830 PMC: 11175762. DOI: 10.1097/JS9.0000000000001306.
[Acceptance of digital apps in the follow-up of patients with head and neck tumors].
Weusthof C, Zhu Z, Ruck A, Bolooki A, Schoffski O, Wollenberg B HNO. 2024; 73(2):122-128.
PMID: 38700582 PMC: 11772454. DOI: 10.1007/s00106-024-01463-6.
Struckmeier A, Buchbender M, Lutz R, Kesting M Clin Oral Investig. 2024; 28(5):262.
PMID: 38642146 PMC: 11032275. DOI: 10.1007/s00784-024-05644-z.